mk 0663 has been researched along with Acropachy, Hereditary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bhagirathi Mallikarjunaswamy, M; Prasad, A; Sehgal, A; Shahi, P | 1 |
| Li, S; Xu, Y; Yue, H; Zhang, Z | 1 |
| Fu, WZ; He, JW; Hu, YQ; Li, SS; Liu, YJ; Zhang, ZL | 1 |
| Guo, L; Sun, F; Ye, S | 1 |
| Yang, B; Zhang, H | 1 |
| Li, Z; Wang, D; Wang, S; Yang, Q; Yang, Y | 1 |
1 trial(s) available for mk 0663 and Acropachy, Hereditary
| Article | Year |
|---|---|
Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention.
Topics: Adult; Asian People; China; Dinoprostone; Etoricoxib; Family; Female; Humans; Male; Middle Aged; Organic Anion Transporters; Osteoarthropathy, Primary Hypertrophic; Prospective Studies; Pyridines; Sulfones | 2017 |
5 other study(ies) available for mk 0663 and Acropachy, Hereditary
| Article | Year |
|---|---|
Incomplete primary hypertrophic osteoarthropathy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Etoricoxib; Humans; Male; Middle Aged; Osteoarthropathy, Primary Hypertrophic; Physical Therapy Modalities | 2020 |
Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy.
Topics: DNA Copy Number Variations; Etoricoxib; Humans; Mutation; Organic Anion Transporters; Osteoarthropathy, Primary Hypertrophic; Pedigree | 2021 |
Primary Hypertrophic Osteoarthropathy With SLCO2A1 Mutation in a Chinese Patient Successfully Treated With Etoricoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Etoricoxib; Foot Joints; Hand Joints; Humans; Male; Mutation; Organic Anion Transporters; Osteoarthropathy, Primary Hypertrophic; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Young Adult | 2018 |
Successful treatment of pachydermoperiostosis patients with etoricoxib, aescin, and arthroscopic synovectomy: Two case reports.
Topics: Arthroscopy; Cardiovascular Agents; Combined Modality Therapy; Cyclooxygenase 2 Inhibitors; Escin; Etoricoxib; Humans; Male; Osteoarthropathy, Primary Hypertrophic; Pyridines; Sulfones; Synovectomy; Treatment Outcome; Young Adult | 2017 |
Successful treatment of pachydermoperiostosis with etoricoxib in a patient with a homozygous splice-site mutation in the SLCO2A1 gene.
Topics: Adult; Cyclooxygenase 2 Inhibitors; Dinoprostone; Etoricoxib; Homozygote; Humans; Male; Mutation; Organic Anion Transporters; Osteoarthropathy, Primary Hypertrophic; RNA Splice Sites; Treatment Outcome | 2019 |